PRODUCTS & INNOVATION
ABBOTT Q2 EARNINGS BEAT EXPECTATIONS
Abbott's diverse portfolio and COVID-19 tests show the company's resiliency in an unprecedented time.
Jul 16 2020
Abbott exceeded analysts’ expectations in the second quarter, beating estimates for sales and EPS even as the economy contracted, thanks to the company’s diversified portfolio and a number of significant product approvals and developments that advanced its pipeline.
For the quarter, Abbott’s worldwide sales of $7.3 billion were driven by Diagnostics — including tremendous demand for the company’s COVID-19 tests — and strong growth in Diabetes Care and Nutrition.
The critical nature of Abbott’s products and the company’s strong product pipeline continued to show Abbott’s resiliency in this challenging environment. Given this recovery and momentum, Abbott is now projecting full-year 2020 adjusted diluted EPS of at least $3.25.
These are the key quarter highlights:
For full financials and reconciliation of non-GAAP measures, you can read our press release, or take a look at some additional materials below:
Abbott President and CEO Robert Ford shared his views on second-quarter performance:
Learn more about how we advanced our product pipeline in Q2.
Download a summary of Abbott's earnings highlights here.
*For important safety information on FreeStyle Libre portfolio, please click here.
Abbott's Tests Helping Tackle the Pandemic
Freestyle Libre 2: Next-Gen CGM is Here
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.